RECENT FUNDING ROUNDS


Country Profile Funding round Value Date
47 Labs Healthcare through neuro-simulation. Pre Seed
DOSE In-game currency of the OliveX, fitness metaverse. Private Round USD 4,200,000
SpineZone Developer of personalized treatment programs for neck and back pain. Series A USD 12,000,000
Maridose LLC Biotech - Cannabis R&D. We are a US DEA licensed manufacturer of Schedule 1 drugs. Pre Seed USD 150,000
Pluto Health Smart health assistant providing insights from siloed medical data. Pre Seed
Aarogoya AI AI-enabled SaaS that diagnoses drug-resistant turberculosis (DR-TB) in hours instead of weeks. Seed
Babylon Health Series C USD 550,000,000
Enlitic LLC Developer of machine learning algorithmic tools for analysing medical data. Series B USD 15,000,000
AccuRx Ltd Platform to power communications between patients and their healthcare professionals. Series A GBP 8,800,000
Current Health Ltd Software-based storage platform used by medical teams to monitor vital signs. Venture

MOST ACTIVE ACQUIRERS

Abbvie Inc US 1
Apple Inc US 1

BEST FUNDED


Cancer drug development company.

DNA testing and genome sequencing firm.

Liquid biopsy diagnosis platform.

Developer of machine learning algorithmic tools for analysing medical data.

Global proof engine.

Oxford University spinout focused on designing stem cell drugs to treat age-related diseases.

Developer of personalized treatment programs for neck and back pain.

Platform to power communications between patients and their healthcare professionals.

In-game currency of the OliveX, fitness metaverse.

Maker of a connected electric toothbrush.

Healthcare company

Consortium of healthcare companies focused on accelerating meaningful innovation using blockchain and DLT.

Provider of online mental health tools for college students who suffer from depression and anxiety.

Developer of a personal health data platform that enables any American to collect, personalize, and share a picture of their health data.

Biotech - Cannabis R&D. We are a US DEA licensed manufacturer of Schedule 1 drugs.